Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation.
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Adam
A
Doyle
Departments of Pathology, University Health Network, University of Toronto, Ontario, Canada.
Oyedele
O
Adeyi
Radiology, University Health Network, University of Toronto, Ontario, Canada.
Korosh
K
Khalili
Departments of Pathology, University Health Network, University of Toronto, Ontario, Canada.
Sandra
S
Fischer
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Martin
M
Dib
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Nicolas
N
Goldaracena
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Jayne
J
Dillon
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
David
D
Grant
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Mark
M
Cattral
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Ian
I
McGilvray
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Paul
P
Greig
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Anand
A
Ghanekar
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Leslie
L
Lilly
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Eberhard
E
Renner
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Gary
G
Levy
Multi Organ Transplant Program, University Health Network, University of Toronto, Ontario, Canada.
Nazia
N
Selzner
D000328:Adult; D001706:Biopsy; D031204:Caloric Restriction / Q000009:adverse effects / Q000379:methods*; D046148:Donor Selection / Q000379:methods; D058625:End Stage Liver Disease / Q000401:mortality / Q000601:surgery*; D005234:Fatty Liver / Q000178:diet therapy* / Q000473:pathology; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects / Q000401:mortality; D006801:Humans; D008099:Liver / Q000473:pathology / Q000601:surgery; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D019520:Living Donors / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D066027:Transplant Recipients / Q000706:statistics & numerical data; D016896:Treatment Outcome; D015431:Weight Loss